Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Gossamer Bio, Inc. (4GB.F)

0.7475
+0.0580
+(8.41%)
As of 9:59:01 AM GMT+2. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
114,701
114,701
--
--
--
Operating Expense
174,620
174,620
173,759
218,528
216,049
Operating Income
-59,919
-59,919
-173,759
-218,528
-216,049
Net Non Operating Interest Income Expense
-9,738
-9,738
-11,514
-12,297
-18,679
Other Income Expense
14,022
14,022
5,456
1,447
724
Pretax Income
-55,635
-55,635
-179,817
-229,378
-234,004
Tax Provision
893
893
--
--
--
Net Income Common Stockholders
-56,528
-56,528
-179,817
-229,378
-234,004
Diluted NI Available to Com Stockholders
-56,528
-56,528
-179,817
-229,378
-234,004
Basic EPS
-0.25
--
-1.18
-2.71
-3.13
Diluted EPS
-0.25
--
-1.18
-2.71
-3.13
Basic Average Shares
226,228.0160
--
152,621.6690
84,574.8690
74,843.4820
Diluted Average Shares
226,228.0160
--
152,621.6690
84,574.8690
74,843.4820
Total Operating Income as Reported
-59,919
-59,919
-183,759
-218,593
-216,124
Total Expenses
174,620
174,620
173,759
218,528
216,049
Net Income from Continuing & Discontinued Operation
-56,528
-56,528
-179,817
-229,378
-234,004
Normalized Income
-56,528
-56,528
-169,817
-229,313
-233,929
Interest Income
1,779
1,779
1,997
1,583
761
Interest Expense
11,517
11,517
13,511
13,880
19,440
Net Interest Income
-9,738
-9,738
-11,514
-12,297
-18,679
EBIT
-44,118
-44,118
-166,306
-215,498
-214,564
EBITDA
-39,967
-39,967
-161,921
-211,069
-209,397
Reconciled Depreciation
4,151
4,151
4,385
4,429
5,167
Net Income from Continuing Operation Net Minority Interest
-56,528
-56,528
-179,817
-229,378
-234,004
Total Unusual Items Excluding Goodwill
--
--
-10,000
-65
-75
Total Unusual Items
--
--
-10,000
-65
-75
Normalized EBITDA
-39,967
-39,967
-151,921
-211,004
-209,322
Tax Rate for Calcs
0.0002
0.0002
--
--
--
12/31/2021 - 2/13/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AAGH America Great Health
0.0050
0.00%
 
SANN.SW Santhera Pharmaceuticals Holding AG
14.60
+0.41%
 
ASMB Assembly Biosciences, Inc.
10.71
+2.88%
 
GLYC GlycoMimetics, Inc.
0.2510
+5.15%
 
TARA Protara Therapeutics, Inc.
4.2300
+0.72%
 
SKYE Skye Bioscience, Inc.
1.7400
+0.58%
 
MREO Mereo BioPharma Group plc
2.5250
-1.38%
 
TLSA Tiziana Life Sciences Ltd
1.3300
+1.52%
 
STRO Sutro Biopharma, Inc.
0.8799
-2.23%
 
SLS SELLAS Life Sciences Group, Inc.
1.3200
+0.76%